GSK and Bharat Biotech Partner to Develop Shigella Vaccine:

GSK and Bharat Biotech Partner to Develop Shigella Vaccine:

Daily Current Affairs   /   GSK and Bharat Biotech Partner to Develop Shigella Vaccine:

Change Language English Hindi

Category : Science and Tech Published on: June 14 2025

Share on facebook

Bharat Biotech and pharmaceutical giant GSK have entered into a collaboration to advance the development of GSK’s Shigella vaccine candidate, altSonflex1-2-3. Bharat Biotech will oversee Phase 3 trials, regulatory submissions, and mass manufacturing, while GSK will contribute to the clinical design, seek external funding, and support commercialization.

Recent Post's

2025 © and Powered By Graposs Edutech Private Limited

Terms & Condition Privacy Policy Disclaimer